Brain Tumour
1624 clinical trials
188 cell line models
6 approved drugs
Brain Tumour
Molecular Synopsis
Drugs and clinical candidates

6 drugs have received FDA approval for Brain Tumour:

  • Bevacizumab
  • Carmustine
  • Dexamethasone Sodium Phosphate
  • Everolimus
  • Lomustine

334 drugs have a clinical trial registered for Brain Tumour.

2825 compounds have been tested in Brain Tumour (1942 <= 500nM potency).

Sources:,, ChEMBL.

Clinical trials
There are 1624 clinical trials for Brain Tumour, 983 of which have one or more drug interventions, 641 with no drug intervention.
Cell line models

There are 188 Cell Line Models for Brain Tumour.

Source: COSMIC
Cell line models

Please note the mappings below are based on an imperfect algorithm. If you notice any anomalies please report them to us.

The following terms have been mapped from mesh condition terms to Brain Tumour:
  • Brain Stem Neoplasms
  • Skull Base Neoplasms
  • Medulloblastoma
  • Brain Neoplasms
  • Glioblastoma
The following terms have been mapped from to Brain Tumour:
  • Glioblastoma multiforme that has recurred (come back). It is used with surgery
  • Anaplastic astrocytoma
  • Glioblastoma multiforme (GBM)
  • Cerebral edema (fluid build-up in the brain)
  • Subependymal giant cell astrocytoma in adults and children aged 1 year or older who have tuberous sclerosis and are not able to have surgery